Strober, B., Papp, K. A., Flack, M., Gu, Y., Thompson, E. H., & Valdecantos, W. C. (2017). Distribution of Improvements in Psoriasis Area and Severity Index from the Phase 2 Trial of Risankizumab in Moderate-to-Severe Plaque Psoriasis. SKIN The Journal of Cutaneous Medicine, 1(3.1), s10. https://doi.org/10.25251/skin.1.supp.9